The program discusses recent developments in the diagnosis, treatment and prevention of Alzheimer’s Disease, as well as changes in the public’s understanding and awareness of the illness.
Guests:
Dale Bredesen, professor, director and CEO of the Buck Institute for Age Research
William H. Fischer, CEO of the Alzheimer's Association's northern California and northern Nevada Chapter
Adam Boxer, neurologist and assistant professor in the Department of Neurology at UCSF as well as director of the Alzheimer's Clinical Trials Program at the UCSF Memory and Aging Center
Donna Schempp, program director at the Family Caregiver Alliance
Sponsored